Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 408
Selected: 0
NCT IDTitle
NCT02575157Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates
NCT00738829Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
NCT02284633Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer
NCT00127036Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
NCT04671693A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.
NCT01471470Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
NCT00957866Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity
NCT02310503Spanish Registry of Mohs Surgery
NCT00384566A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure
NCT01428414Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer
NCT05525858KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
NCT00144976Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma
NCT03224208Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients
NCT00744640Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma
NCT05651724Global Research Initiative for Patients Screening on MASH
NCT03654833Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma
NCT02899065Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department
NCT01118234Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
NCT02012634Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer
NCT01508000Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases
NCT05798312Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material
NCT04144270The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
NCT00333437Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
NCT01450137Tocilizumab for Patients With Giant Cell Arteritis
NCT00459771Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
NCT00293072Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
NCT04484636PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
NCT00391248Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)
NCT05293015NP-Supported Multidisciplinary Diabetes Management During Perioperative Period
NCT03341520Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma
NCT06008691A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
NCT03272477Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients
NCT01321957Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer
NCT04702256Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
NCT02676947A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension
NCT03340376Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer
NCT02319941Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
NCT00483405Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
NCT02389842PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib
NCT00193609Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
NCT01368848Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
NCT03134794Medical Education for Better Multiple Sclerosis Outcomes
NCT00612586Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer
NCT02370524Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease
NCT03697850Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy
NCT01016639Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer
NCT05825261Exploring Novel Biomarkers for Emphysema Detection
NCT01661790Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
NCT05306041Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer
NCT00865982Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer